A fluorescence immunoanalyzer system for cardiac biomarker detection. The AFIAS-3 enables testing of cardiac markers such as troponin, myoglobin, CK-MB, NT-proBNP, BNP, D-Dimer, ST2, and PCT.
Manufactured by
Chinmax Boditech(Shanghai) Co. Ltd.
China
Chinmax Boditech is a joint venture established in 2017 between Korea's Boditech Med Inc. and Shanghai Dejihang Technology. Boditech Med Inc., founded in 1998 and publicly listed in Korea since 2015, is a global IVD leader with innovative whole blood rapid diagnostic technology, exporting to over 70 countries. The company focuses on marketing AFIAS immunoassay products in the Chinese market.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Chongqing Isia Bio-Technology Co Ltd
China · 2 relevant products
MEDICALSK
South Korea · 1 relevant product
Boditech Med Inc.
South Korea · 4 relevant products
23 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 8 relevant matches
Quidel China Ltd. · China
Cardiac Injury Triple Test Kit using fluorescence immunoassay technology for rapid detection of cardiac biomarkers. Enables simultaneous measurement of multiple cardiac injury markers to support acute coronary syndrome diagnosis and risk stratification in clinical laboratory and point-of-care settings.
Shenzhen Diasia Biomedical Technology Co.,Ltd · China
A high-precision analyzer utilizing fluorescence immunoassay (FIA) technology for rapid immunological testing and diagnosis. The system is designed for clinical chemistry and immunofluorescence applications in point-of-care testing.
Xiamen Biotime Biotechnology Co., Ltd. · China
Fluorescence immunoassay test for cardiac marker detection. Used for assessment of myocardial injury and cardiac risk evaluation.
5 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products